EXACT SCIENCES CORPORATION - ONCOTYPE DX BREAST CANCER TESTING

PIID: 36C26024F0122

Signed Date: Dec 10, 2025Effective Date: Jan 1, 2024End Date: Closes in 203 days

Award $

$86K

Vendor

EXACT SCIENCES CORPORATION

NAICS

621511

Signed Date

Dec 10, 2025

Key Details

Dollars Obligated

$86,349

Base & All Options

$41,447.52

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

621511 - MEDICAL LABORATORIES

Product Service Code

Q301 - REFERENCE LABORATORY TESTING

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

BOISE, ID, 837024501, CD-ID-02

Description

ONCOTYPE DX BREAST CANCER TESTING

Context & Analysis

On Dec 10, 2025, Department of Veterans Affairs obligated $86,349 to EXACT SCIENCES CORPORATION for oncotype dx breast cancer testing. The award is classified under NAICS 621511 — MEDICAL LABORATORIES and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in BOISE, ID. The contract is scheduled through Dec 31, 2026 — approximately 7 months remaining.